National Comprehensive Cancer Network



NCCN Guidelines®
NCCN Compendium®
About the NCCN Compendium®
NCCN Compendium® Chapters By Disease
Subscribe to the NCCN Compendium
Transparency: Process and Recommendations
No Longer Recommended Uses
JNCCN — Journal of the National Comprehensive Cancer Network

NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) are posted with the latest update date and version number.

The NCCN Guidelines are copyrighted by the NCCN. All rights reserved. NCCN Guidelines and illustrations (including algorithms) may not be reproduced in any form for any purpose without the express written permission of the NCCN. Permissions Requests Section.

Click here to view the NCCN Guidelines Panel Members individual disclosures

NCCN Guidelines for Treatment of Cancer by Site

NCCN Guidelines for Detection, Prevention, & Risk Reduction

NCCN Guidelines for Supportive Care

NCCN Guidelines for Age Related Recommendations

NCCN Guidelines for Patients




Although the look of our website has changed, the NCCN Guidelines® are still FREE. Click on the cancer types below to display a drop down of options. If you are still having an issue, please contact us.

If you can see this message there appears to be an issue with the javascript in your browser. Please click here to view the NCCN Guidelines without javascript.

NCCN GUIDELINES FOR TREATMENT OF CANCER BY SITE

Acute Lymphoblastic Leukemia   
Bladder Cancer   
Bone Cancer   
Cancer of Unknown Primary (See Occult Primary)
Central Nervous System Cancers   
  • NCCN Guidelines
  • Adult Low-Grade Infiltrative Supratentorial Astrocytoma/Oligodendroglioma (excluding pilocytic astrocytoma)
  • Anaplastic Gliomas/Glioblastoma
  • Adult Intracranial Ependymoma
  • Adult Medulloblastoma and Supratentorial PNET
  • Primary CNS Lymphoma
  • Primary Spinal Cord Tumors
  • Meningiomas
  • Limited (1-3) Metastatic Lesions
  • Multiple (>3) Metastatic Lesions
  • Leptomeningeal Metastases
  • Metastatic Spine Tumors
Cutaneous Melanoma (See Melanoma)
Endometrial Cancer (See Uterine Neoplasms)
Esophageal and Esophagogastric Junction Cancers   
Fallopian Tube Cancer (See Ovarian Cancer)
Head and Neck Cancers   
Hepatobiliary Cancers   
Multiple Myeloma/Other Plasma Cell Neoplasms
Systemic Light Chain Amyloidosis   
Waldenström's Macroglobulinemia / Lymphoplasmacytic Lymphoma   
Neuroendocrine Tumors   
  • NCCN Guidelines
  • Carcinoid Tumors
  • Islet Cell Tumors (Pancreatic Endocrine Tumors)
  • Neuroendocrine Unknown Primary
  • Adrenal Gland Tumors
  • Pheochromocytoma
  • Poorly Differentiated (High Grade or Anaplastic)/Small Cell
  • Multiple Endocrine Neoplasia, Type 1
  • Multiple Endocrine Neoplasia, Type 2
Non-Hodgkin's Lymphomas   
  • NCCN Guidelines
  • NCCN Educational Events and Programs
  • NCCN International Translations/Adaptations
  • Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
  • Follicular Lymphoma
  • Marginal Zone Lymphoma
  • Mantle Cell Lymphoma
  • Diffuse Large B-Cell Lymphoma
  • Burkitt Lymphoma
  • Lymphoblastic Lymphoma
  • AIDS-Related B-Cell Lymphoma
  • Primary Cutaneous B-Cell Lymphoma
  • Peripheral T-Cell Lymphoma
  • Mycosis Fungoides/Sézary Syndrome
  • Primary Cutaneous CD30+ T-Cell Lymphoproliferative Disorders
  • T-cell Large Granular Lymphocytic Leukemia
  • Adult T-Cell Leukemia/Lymphoma
  • Extranodal NK/T- Cell Lymphoma, nasal type
  • Post-Transplant Lymphoproliferative Disorders
  • T-Cell Prolymphocytic Leukemia
  • Hairy Cell Leukemia
Non-Melanoma Skin Cancers
Dermatofibrosarcoma Protuberans   
Squamous Cell Skin Cancer   
Ovarian Cancer   
Primary Peritoneal Cancer (See Ovarian Cancer)
Small Cell Lung Cancer      20th Annual Edition!
Soft Tissue Sarcoma   
Thymomas and Thymic Carcinomas   
Thyroid Carcinoma   
  • NCCN Guidelines
  • Nodule Evaluation
  • Papillary Carcinoma
  • Follicular Carcinoma
  • Hürthle Cell Neoplasm
  • Medullary Carcinoma
  • Anaplastic Carcinoma
Uterine Neoplasms   

NCCN GUIDELINES FOR DETECTION, PREVENTION, & RISK REDUCTION


Breast Cancer
Breast Cancer Risk Reduction   
Breast Cancer Screening and Diagnosis   
Genetic/Familial High-Risk Assessment: Breast and Ovarian   
Cervical Cancer Screening   

The NCCN Guidelines Panel for Cervical Cancer Screening endorses the following guidelines:

  • For the prevention and early detection of cervical cancer: American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. Am J Clin Pathol 2012;137:516-542. Available at: http://ajcp.ascpjournals.org/content/137/4/516.long
  • For the management of abnormal cervical screening tests and cancer precursors: 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. J Low Genit Tract Dis 2013;17(5 Suppl 1):S1-S27. Available at: http://www.asccp.org/
Colorectal Cancer
Colorectal Cancer Screening   
Genetic/Familial High-Risk Assessment: Colorectal   
Lung Cancer Screening   
Prostate Cancer Early Detection   

NCCN GUIDELINES FOR SUPPORTIVE CARE


Cancer- and Chemotherapy-Induced Anemia   
Cancer-Associated Venous Thromboembolic Disease   
Cancer-Related Fatigue   
Prevention and Treatment of Cancer-Related Infections   
Survivorship   
  • NCCN Guidelines
  • Anxiety and Depression
  • Cognitive Function
  • Exercise
  • Fatigue
  • Immunizations and Infections
  • Pain
  • Sexual Function (female/male)
  • Sleep Disorders

NCCN GUIDELINES FOR AGE RELATED RECOMMENDATIONS


Adolescent and Young Adult (AYA) Oncology   
Senior Adult Oncology   

Click here to order the latest flash drive of the Complete Library of NCCN Guidelines®.

Disclaimer
The NCCN Guidelines are a statement of consensus of the authors regarding their views of currently accepted approaches to cancer treatment. The recommendations regarding the uses and indications in the NCCN Compendium have been derived directly from the NCCN Guidelines. The NCCN Compendium represents neither an all-inclusive listing of every drug and biologic nor every appropriate use and indication for drugs and biologics. The NCCN Templates are peer reviewed statements of consensus of their authors derived from the NCCN Guidelines for the conditions the NCCN Templates address. The NCCN Templates are not exhaustive and do not represent the full spectrum of care or treatment options described in the NCCN Guidelines or the NCCN Compendium or include all appropriate approaches or combinations of drugs or biologics for the treatment of cancer. A NCCN Template does not constitute an order.

Web Citation for NCCN Guidelines

Help with Viewing the NCCN Guidelines

Please note that the guidelines listed are Acrobat PDF files. To view these files the Acrobat Reader plug-in must be installed in your browser. Click here for further instructions and a link to the free download site if needed.

Please maximize your browser window to view these guidelines. Please note that there may be a delay of several seconds to a minute or more, depending on the speed of your connection, as the PDFs download into your browser window.